223 related articles for article (PubMed ID: 11278482)
1. Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death.
Mercatante DR; Bortner CD; Cidlowski JA; Kole R
J Biol Chem; 2001 May; 276(19):16411-7. PubMed ID: 11278482
[TBL] [Abstract][Full Text] [Related]
2. Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents.
Mercatante DR; Mohler JL; Kole R
J Biol Chem; 2002 Dec; 277(51):49374-82. PubMed ID: 12381725
[TBL] [Abstract][Full Text] [Related]
3. Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines.
Li Z; Li Q; Han L; Tian N; Liang Q; Li Y; Zhao X; Du C; Tian Y
Oncol Rep; 2016 Feb; 35(2):1013-9. PubMed ID: 26718027
[TBL] [Abstract][Full Text] [Related]
4. Modification of BCLX pre-mRNA splicing has antitumor efficacy alone or in combination with radiotherapy in human glioblastoma cells.
Dou Z; Lei H; Su W; Zhang T; Chen X; Yu B; Zhen X; Si J; Sun C; Zhang H; Di C
Cell Death Dis; 2024 Feb; 15(2):160. PubMed ID: 38383492
[TBL] [Abstract][Full Text] [Related]
5. Modification of alternative splicing of Bcl-x pre-mRNA in bladder cancer cells.
Zhu Z; Xing S; Cheng P; Zeng F; Lu G
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(2):213-6. PubMed ID: 16850750
[TBL] [Abstract][Full Text] [Related]
6. Bcl-x pre-mRNA splicing regulates brain injury after neonatal hypoxia-ischemia.
Xiao Q; Ford AL; Xu J; Yan P; Lee KY; Gonzales E; West T; Holtzman DM; Lee JM
J Neurosci; 2012 Sep; 32(39):13587-96. PubMed ID: 23015448
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activity of splice-switching oligonucleotides.
Bauman JA; Li SD; Yang A; Huang L; Kole R
Nucleic Acids Res; 2010 Dec; 38(22):8348-56. PubMed ID: 20719743
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x.
Garneau D; Revil T; Fisette JF; Chabot B
J Biol Chem; 2005 Jun; 280(24):22641-50. PubMed ID: 15837790
[TBL] [Abstract][Full Text] [Related]
9. Identification of two RNA cis-elements that function to regulate the 5' splice site selection of Bcl-x pre-mRNA in response to ceramide.
Massiello A; Salas A; Pinkerman RL; Roddy P; Roesser JR; Chalfant CE
J Biol Chem; 2004 Apr; 279(16):15799-804. PubMed ID: 14734550
[TBL] [Abstract][Full Text] [Related]
10. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides.
Taylor JK; Zhang QQ; Wyatt JR; Dean NM
Nat Biotechnol; 1999 Nov; 17(11):1097-100. PubMed ID: 10545916
[TBL] [Abstract][Full Text] [Related]
11. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1.
Chalfant CE; Rathman K; Pinkerman RL; Wood RE; Obeid LM; Ogretmen B; Hannun YA
J Biol Chem; 2002 Apr; 277(15):12587-95. PubMed ID: 11801602
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase 1 activation and alternative splicing of Bcl-X and Mcl-1 by EGCG + ibuprofen.
Kim MH
J Cell Biochem; 2008 Jul; 104(4):1491-9. PubMed ID: 18348186
[TBL] [Abstract][Full Text] [Related]
13. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U
J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472
[TBL] [Abstract][Full Text] [Related]
14. Relative strength of 5' splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA.
Choi N; Liu Y; Oh J; Ha J; Ghigna C; Zheng X; Shen H
BMB Rep; 2021 Mar; 54(3):176-181. PubMed ID: 33050987
[TBL] [Abstract][Full Text] [Related]
15. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells.
Yamanaka K; Rocchi P; Miyake H; Fazli L; Vessella B; Zangemeister-Wittke U; Gleave ME
Mol Cancer Ther; 2005 Nov; 4(11):1689-98. PubMed ID: 16275990
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells.
Butt AJ; Firth SM; King MA; Baxter RC
J Biol Chem; 2000 Dec; 275(50):39174-81. PubMed ID: 10998426
[TBL] [Abstract][Full Text] [Related]
17. Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene.
Pecci A; Viegas LR; Baranao JL; Beato M
J Biol Chem; 2001 Jun; 276(24):21062-9. PubMed ID: 11274164
[TBL] [Abstract][Full Text] [Related]
18. Low doses of alpha particle irradiation modify the expression of genes regulating apoptosis in human MCF-7 breast cancer cells.
Soto J; Sainz C; González-Lamuño D; Cos S
Oncol Rep; 2006 Mar; 15(3):577-81. PubMed ID: 16465415
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing of BCL-x is controlled by RBM25 binding to a G-quadruplex in BCL-x pre-mRNA.
Le Sénéchal R; Keruzoré M; Quillévéré A; Loaëc N; Dinh VT; Reznichenko O; Guixens-Gallardo P; Corcos L; Teulade-Fichou MP; Granzhan A; Blondel M
Nucleic Acids Res; 2023 Nov; 51(20):11239-11257. PubMed ID: 37811881
[TBL] [Abstract][Full Text] [Related]
20. Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers.
Kitamura S; Kondo S; Shinomura Y; Kanayama S; Miyazaki Y; Kiyohara T; Hiraoka S; Matsuzawa Y
Br J Cancer; 2000 Sep; 83(5):668-73. PubMed ID: 10944610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
